| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.09 | 0.1 |